MIH celebrates International Clinical Trial Day

Islamabad : Maroof International Hospital (MIH) celebrated Int’l Clinical Trial Day, highlighting the crucial role of clinical trials in medical advancements. Key speakers provided compelling statistics and committed to furthering research excellence, says a press release.

Dr. Waqar Hafeez, Consultant Neurologist & Executive Director of Maroof Clinical Trial Unit, emphasised the surge in clinical trials in Pakistan. “Data from clinicaltrials.gov reveals a dramatic increase in the number of clinical trials: 469 conducted in 2023 compared to just 215 in 2019,” he highlighted, underscoring the critical need for robust clinical research, especially post-COVID. Ch. Naseer Ahmed, chairman MIH congratulated the research team for their commitment to excellence. “Dr. Mujtaba Qadri & Dr. Mir Waheed have been the pioneers, and under Dr. Saboora Waris’ leadership, our clinical trial unit has achieved new heights,” he said.

Haroon Naseer, CEO MIH, reaffirmed the hospital’s dedication to advancing medical research. “We will continue pushing the boundaries of medical research to ensure our patients receive the most advanced and effective treatments,” he said, praising the MIH research department’s growth from humble beginnings to a national leader.

Dr. Mir Abdul Waheed, medical director MIH, celebrated the unit’s dedication to life-saving research, announcing, “Our renewal of the DRAP license for Maroof Clinical Trial Unit is a testament to our commitment to conducting high-quality & safe clinical research.”